Dr. Reddy’s dermatologicals
Executive Summary
The Indian drugmaker plans to launch three branded dermatological products in the U.S. by the end of 2009 through its newly-established Bridgewater, N.J.-based Promius Pharma subsidiary. The products, which were in-licensed and co-developed, include: EpiCeram skin barrier emulsion for atopic dermatitis, Scytera foam for psoriasis and Promiseb cream for seborrheic dermatitis. Other topical products are in development. Dr. Reddy's established Promius as a platform for its U.S. branded specialty drug business (1PharmAsia News, Aug. 19, 2008)